Site Search
Company Search
Get Quote
"The QualityStocks Daily", our free summary formatted newsletter containing stock tips from hundreds of online investment newsletters.
QualityStocksNewsBreaks
- 2:30 pm QualityStocksNewsBreaks – Zacks Research Releases Updated Report as Soligenix Inc. (NASDAQ: SNGX) Eyes Upcoming ‘Key Catalysts’
- 11:20 am QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Launches AI Module to Accelerate Development of Targeted Cancer Combination Therapies
- 9:40 am QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) to Launch AI-Integrated Culinary School With Majority Stake in Modern Culinary Systems
QualityStocks Articles
- 9:45 am Safe Pro Group Inc. (NASDAQ: SPAI) to Benefit from $33 Billion US Defense Bill Targeting AI and Drone Innovation
- 9:00 am Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Takes Key Step and Leads as Critical Minerals Demand Continues to Climb
- 10:30 am AI Robotics are Transforming Hotels – And the Shift Has Already Begun
QualityStocksSpotlight Company
CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
Investment Considerations CNS Pharmaceuticals’ lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (GBM), an aggressive and currently incurable form of brain cancer. In a Phase I clinical trial of Berubicin in malignant brain tumors, 44% of patients experienced a statistically significant improvement in clinical benefit. In preclinical studies, the company’s second … Continue reading “CNS Pharmaceuticals Inc. (NASDAQ: CNSP)”
Latest Press Releases
Filter Releases
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |
Interested in a live, online demonstration?
Get a walkthrough of our products and services.
- Recognize the difference of our innovative, all-encompassing approach
- See how we will drive results for your company
- Understand the power of our partnerships to extend your reach and recognition in the investment community and beyond
